BBNX vs HUBS · rev $100.3M vs P/E 96, rev $1.79B
Beta Bionics, Inc. Common Stock (BBNX) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
BBNX currently screens at market cap $640.8M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the BBNX and HUBS stock pages for the full models.
Not investment advice.